TEVA ▲ +0.1% - Teva Pharmaceutical Industries Limited $TEVA - S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline Teva Pharmaceutical Industries rose 0.1% following a credit rating upgrade from S&P Global Ratings to BBB-, the company's third upgrade in recent months. The upgrade reflects S&P's assessment of Teva's strong execution and financial discipline, improvements that typically signal reduced borrowing costs and lower financial risk to investors. 04-SEP-2026 11:30 AM ET